OncoSec Medical Inc. | Income Statement

Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
736.90
780.10
664.60
355.60
380.00
334.50
Gross Income
736.90
780.10
664.60
355.60
380.00
334.50
SG&A Expense
6,328.10
11,169.60
20,576.50
26,530.50
21,068.40
35,770.90
EBIT
7,065.00
11,949.70
21,241.10
26,886.10
21,448.40
36,105.40
Interest Expense
83.20
20.70
-
-
-
-
Pretax Income
7,148.20
11,970.30
21,241.10
26,886.10
21,448.40
39,135.70
Income Tax
2.00
41.80
2.00
2.50
1.40
0.70
Consolidated Net Income
7,150.20
12,012.10
21,243.10
26,888.50
21,449.80
39,136.40
Net Income
7,150.20
12,012.10
21,243.10
26,888.50
21,449.80
39,136.40
Net Income After Extraordinaries
7,150.20
12,012.10
21,243.10
26,888.50
21,449.80
39,136.40
Net Income Available to Common
7,150.20
12,012.10
21,243.10
26,888.50
21,449.80
39,136.40
EPS (Basic)
1.40
1.20
1.67
1.63
1.06
9.80
Basic Shares Outstanding
5,327.90
9,527.20
12,709.00
16,514.70
20,189.70
4,012.30
EPS (Diluted)
1.34
1.26
1.67
1.63
1.06
9.75
Diluted Shares Outstanding
5,327.90
9,527.20
12,709.00
16,514.70
20,189.70
4,012.30
EBITDA
6,328.10
11,169.60
20,576.50
26,530.50
21,068.40
35,770.90

About OncoSec Medical

View Profile
Address
3565 General Atomics Court
San Diego California 92121
United States
Employees -
Website http://www.oncosec.com
Updated 07/08/2019
OncoSec Medical, Inc. engages in the design and commercialize medical products for the treatment of cancer. It involves in the discovery and development of novel immunotherapeutic products to improve treatment options for patients and physicians, which intends to treat oncology indications. The company was founded by Avtar S.